Beijing uses anti-HIV drugs to treat corona virus
Beijing's government says some of the city's hospitals are giving patients with Corona virus, which has flared up from Wuhan, to apply anti-HIV drug treatments.
Browse ScienceInfo articles and explainers related to Anti HIV.
24 published items.
Beijing's government says some of the city's hospitals are giving patients with Corona virus, which has flared up from Wuhan, to apply anti-HIV drug treatments.
The study is expected to help completely change the way snakebite cases are handled globally
A special gel developed in Kenya can kill the AIDS virus that is entering an important testing phase.
US scientists have successfully prepared an experimental vaccine, which for the first time completely destroys the immunodeficiency virus, similar to the HIV virus that…
On September 24, a vaccine showed the effectiveness of HIV prevention, the announcement was made in Thailand to bring hope to many people ...
The scientific community was surprised to find an antibody that could help kill 99% of HIV viruses, opening a new direction for medicine.
Antiretroviral therapy is mainly outpatient and is indicated when the patient has clinical criteria, and / or tests and proves to be ready for treatment.
Occupational HIV exposure of health-care providers is quite common, but not all exposures lead to infection. This is the risk that every health worker must face.
ARV is a treatment for people with HIV, which reduces the development of HIV and slows the HIV phase to AIDS.
By injecting antibodies directly into cells, scientists have created a new generation of cells capable of protecting themselves from HIV.
AZT is the first HIV drug in the world. However, before being passed, it also caused much controversy in the scientific world.
Chinese scientists use CRISPR / Cas9 gene editing tools to create anti-HIV embryos.
The medical community published the case that the first patient with HIV could resist the development of the virus without taking the drug for 12 years.
Russian scientists from Novosibirsk claim they have reached the second stage in clinical trials of vaccines against HIV and AIDS.
Scientists believe that the unique appearance of an antibody can effectively block the HIV attack.